First-In-Human Phase I Study of Lurbinectedin (PM01183) in Patients With Advanced Solid Tumors
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-13-1880
Full Text
Open PDFAbstract
Available in full text
Date
February 21, 2014
Authors
Publisher
American Association for Cancer Research (AACR)